| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,279 |
2,188 |
$90K |
| 62323 |
|
180 |
170 |
$17K |
| 64483 |
|
76 |
75 |
$6K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
52 |
52 |
$5K |
| 64484 |
|
74 |
73 |
$2K |
| 27096 |
|
45 |
39 |
$2K |
| 64495 |
|
27 |
25 |
$1K |
| 64494 |
|
27 |
25 |
$1K |
| 64493 |
|
15 |
13 |
$1K |
| J3490 |
Unclassified drugs |
682 |
625 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
890 |
863 |
$733.37 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
93 |
83 |
$458.12 |
| 77003 |
|
212 |
205 |
$393.45 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
442 |
435 |
$69.24 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
24 |
23 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
35 |
34 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
37 |
36 |
$0.00 |
| G9578 |
Documentation of signed opioid treatment agreement at least once during opioid therapy |
37 |
36 |
$0.00 |
| G9562 |
Patients who had a follow-up evaluation conducted at least every three months during opioid therapy |
36 |
35 |
$0.00 |
| G9744 |
Patient not eligible due to active diagnosis of hypertension |
13 |
13 |
$0.00 |
| 99070 |
|
386 |
360 |
$0.00 |